Noicattaro, Italy

Giovanni Tesoriere

USPTO Granted Patents = 9 

 

Average Co-Inventor Count = 7.0

ph-index = 3

Forward Citations = 33(Granted Patents)


Company Filing History:


Years Active: 2020-2025

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Giovanni Tesoriere: Innovator in Radionuclide Solutions

Introduction

Giovanni Tesoriere is a notable inventor based in Noicattaro, Italy. He has made significant contributions to the field of radionuclide complex solutions, holding a total of eight patents. His work focuses on enhancing the stability and concentration of these solutions for medical applications.

Latest Patents

Among his latest patents, Giovanni Tesoriere has developed stable, concentrated radionuclide complex solutions. This invention relates to radionuclide complex solutions that exhibit high concentration and chemical stability, making them suitable for use as drug products in diagnostic and therapeutic settings. The stability of these drug products is achieved through the incorporation of at least one stabilizer to prevent radiolytic degradation. Notably, the use of two stabilizers introduced at different stages during the manufacturing process has proven particularly advantageous.

Career Highlights

Throughout his career, Giovanni Tesoriere has worked with prominent companies in the field, including Advanced Accelerator Applications S.A. and Advanced Accelerator Applications (Italy) S.r.l. His expertise in radionuclide solutions has positioned him as a key figure in the development of innovative medical products.

Collaborations

Giovanni has collaborated with several professionals in his field, including Francesco De Palo and Lorenza Fugazza. These collaborations have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Giovanni Tesoriere's work in the field of radionuclide complex solutions showcases his innovative spirit and dedication to improving medical diagnostics and therapies. His contributions continue to impact the industry positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…